Brello Health Tirzepatide Cost: Pricing, Prepaid Structure & Fees

Last reviewed: September 13, 2026 Last updated: September 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Brello Health charges $499 upfront for compounded tirzepatide injection, covering an 11-week supply with no membership fee, no service fee, and no hidden charges. The company markets this as $166.33 per month by dividing $499 by three, but because 11 weeks is shorter than a calendar quarter, the charge recurs 4.727 times per year—yielding an annualized effective cost of $196.56 per month over 12 months (our calculation, based on $499 × 4.727 cycles). Brello also offers compounded semaglutide injection at $399 for a three-month supply (three-month minimum commitment; our calculation: $133/month effective rate assuming automatic quarterly renewal). By comparison, PlexusDx tirzepatide injection costs $289 per month billed month-to-month, or $269 per month prepaid in three-month blocks, with no upfront commitment and the same flat rate at every dose. Brello's tirzepatide option costs less than PlexusDx month-to-month over a full year ($2,359 vs. $3,468, our calculation), but requires a $499 charge every 11 weeks; PlexusDx offers the flexibility to cancel or skip a month without forfeiting a prepaid balance and provides a verified 4.3-star Trustpilot rating (79% five-star, 83% four stars or higher, captured September 9, 2026). Choose Brello if upfront budgeting and a lower annualized cost outweigh billing flexibility; choose PlexusDx if you want predictable monthly charges, multi-month prepaid discounts without odd billing cycles, and a documented service record.

At-a-glance comparison: Brello Health vs. PlexusDx tirzepatide

Sources: Brello Health tirzepatide checkout page captured September 4, 2026; PlexusDx pricing confirmed September 13, 2026; PlexusDx Trustpilot rating captured September 9, 2026.

Brello Health tirzepatide pricing structure

Brello Health sells compounded tirzepatide injection for $499 upfront, covering an 11-week supply (tirzepatidewoo.brellohealth.com, captured September 4, 2026). The charge recurs automatically every 11 weeks, and you may cancel anytime before the next rebill. Brello markets the plan as $166.33 per month by dividing $499 by three, but 11 weeks equals approximately 2.54 calendar months. Over a full year (52 weeks), 11-week cycles repeat 4.727 times, so the total annual cost is $499 × 4.727 = $2,358.77 (our calculation). Divided by 12 months, that yields an effective monthly rate of $196.56 (our calculation). The upfront figure and the marketed per-month figure are both accurate within their stated frames; the difference matters if you are comparing annualized budgets or prefer to think in calendar months rather than 11-week intervals.

The $499 charge is all-inclusive: medication, provider consultations, and shipping are bundled with no separate membership fee and no service fee (brellohealth.com, captured September 4, 2026). Brello does not publish per-dose pricing tiers on its public checkout pages; confirm whether dose increases trigger a price change by contacting support before your first order.

Brello Health semaglutide pricing (for context)

Brello also offers compounded semaglutide injection at $399 for a three-month supply, billed upfront with a three-month minimum commitment (brellohealth.com/home1, captured September 4, 2026). Dividing $399 by three yields $133 per month (prepaid per-month equivalent, our calculation). The evidence does not confirm whether semaglutide rebills automatically every three months like tirzepatide rebills every 11 weeks, or whether a new purchase is required; you should confirm renewal terms at checkout. Assuming automatic quarterly renewal, the 12-month cost is $399 × 4 = $1,596, or $133 per month effective (our calculation). The same all-inclusive model applies: no membership fee, no service fee, medication and provider access bundled.

PlexusDx tirzepatide pricing (like-for-like comparison)

PlexusDx compounded tirzepatide injection costs $289 per month on a month-to-month plan, billed monthly with no upfront commitment and no membership fee (plexusdx.com/products/tirzepatide-injection, confirmed September 13, 2026). Over 12 months the total is $289 × 12 = $3,468 (our calculation). Prepaid options lower the effective monthly rate: a three-month prepaid plan costs $269 per month ($807 per quarter, $3,228 annualized, our calculation), and a six-month prepaid plan costs $249 per month ($1,494 per half-year, $2,988 annualized, our calculation). Prepaid balances are non-refundable, but month-to-month subscribers can cancel or skip a month without forfeiting a prepaid charge. The same flat rate applies at every tirzepatide dose—2.5 mg through 15 mg—so titration does not change your monthly bill.

PlexusDx also includes medication, provider access, and shipping in the published price, and works with licensed 503A compounding pharmacies. The company holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (trustpilot.com/review/plexusdx.com, captured September 9, 2026).

Normalized 12-month cost comparison

When you annualize each plan over a full 12 months and account for billing cadence, the economic picture shifts:

All derived figures labeled "our calc" or "prepaid" are our calculations based on the published per-cycle or per-month rates and the stated billing cadence. Confirm final totals at checkout.

Key insight: Brello's tirzepatide plan costs $1,109 less per year than PlexusDx month-to-month ($2,359 vs. $3,468, our calculation), and $629 less than PlexusDx's six-month prepaid option ($2,359 vs. $2,988, our calculation). That savings comes at the cost of an 11-week billing cycle—your credit card is charged $499 roughly every 2.5 months rather than a predictable calendar-month interval. If you prefer to budget in calendar months or want the option to skip a single month without forfeiting a prepaid balance, PlexusDx month-to-month offers that flexibility at a higher annualized cost. If you are comfortable with the 11-week cadence and want the lowest total annual spend, Brello's structure delivers measurable savings.

What the price includes (and what it doesn't)

Both Brello Health and PlexusDx bundle medication, provider consultations, and shipping into the published price with no separate membership fee and no service fee. Neither program guarantees a specific starting dose, ongoing dose, or result—a licensed clinician reviews your intake, medical history, and progress to determine whether a prescription is appropriate and which dose is suitable at each refill.

Brello's public checkout pages do not detail per-dose pricing tiers for tirzepatide; confirm whether moving from 2.5 mg to 5 mg or higher triggers a price change by contacting support before your first order. PlexusDx explicitly charges the same flat rate at every tirzepatide dose (2.5 mg through 15 mg), so titration does not change your monthly bill.

Both programs dispense compounded tirzepatide. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Cancellation, pausing, and flexibility

Brello Health states that tirzepatide subscribers may cancel anytime before the next 11-week rebill (tirzepatidewoo.brellohealth.com, captured September 4, 2026). Once a $499 charge posts, that 11-week supply is prepaid and non-refundable. The evidence does not confirm whether Brello allows you to pause or skip a cycle while remaining enrolled, or whether cancellation requires re-enrollment if you wish to restart; contact support to clarify pause and re-enrollment terms.

PlexusDx month-to-month subscribers can cancel at any time with no early-termination fee; you simply stop the recurring charge and are not billed again. Prepaid PlexusDx plans (three-month and six-month) are non-refundable, but once the prepaid term ends you may choose not to renew, effectively pausing without penalty. Month-to-month plans offer maximum flexibility for travelers, seasonal users, or anyone testing tolerance; prepaid plans lock in a lower effective rate in exchange for an upfront commitment.

Service quality and transparency: what the review record shows

Brello Health maintains a Trustpilot profile (checked September 4, 2026), but no rating, review volume, or negative themes were captured in this research pass. We cannot make comparative service-quality claims without published review evidence. You may wish to search Trustpilot and Reddit independently for recent Brello user reports before committing to an 11-week prepaid cycle.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (trustpilot.com/review/plexusdx.com, captured September 9, 2026). That record provides some visibility into shipping speed, provider responsiveness, and customer-support experience. No telehealth provider guarantees results or side-effect outcomes, but a documented review history offers a check on operational reliability that is harder to assess for newer or less-reviewed competitors.

Choose Brello Health if…

• You want the lowest annualized tirzepatide cost among the options in this comparison ($2,359/year, our calculation) and are comfortable with a $499 charge every 11 weeks.
• An 11-week billing cycle aligns with your budgeting rhythm, or you prefer fewer transactions per year over calendar-month predictability.
• You value no membership fee and an all-inclusive flat rate, and you do not need a documented multi-year review history to proceed.
• You plan to stay on tirzepatide continuously for at least one full cycle and do not anticipate needing to pause or skip a month mid-term.

Confirm at checkout whether dose increases change the $499 rate, and clarify pause and re-enrollment terms if you think you may need to interrupt treatment.

Choose PlexusDx if…

• You want predictable calendar-month billing and the flexibility to cancel or skip a month without forfeiting a prepaid balance (month-to-month plan).
• You prefer a documented service record—PlexusDx's 4.3-star Trustpilot rating and 83% four-star-or-higher review rate offer transparency on shipping, provider access, and support responsiveness.
• You value explicit dose-agnostic pricing: the same flat rate at 2.5 mg, 5 mg, 10 mg, or 15 mg, so titration never surprises you with a mid-cycle price jump.
• You want the option to lock in a lower effective rate with a prepaid plan ($269/month for three months, $249/month for six months) while still billing on a standard quarterly or half-year cycle, rather than an 11-week interval.
• You are traveling, testing tolerance, or managing a variable schedule, and maximum month-to-month flexibility is worth a higher per-month cost.

Methodology and freshness

We captured Brello Health's tirzepatide and semaglutide pricing from public checkout pages on September 4, 2026 (tirzepatidewoo.brellohealth.com and brellohealth.com/home1). PlexusDx pricing was confirmed from internal product data on September 13, 2026. All 12-month totals, effective monthly rates, and annualized cycle counts are our calculations based on the published per-cycle or per-month rates and the stated billing cadence; we labeled every derived figure accordingly. Trustpilot data for PlexusDx was captured September 9, 2026. Brello's Trustpilot profile was checked September 4, 2026, but no rating or review volume was recorded in this pass. We apply the same evidence and verification rules to PlexusDx and to competing programs. Pricing, fees, and terms can change; confirm all figures at checkout before purchasing.

Frequently Asked Questions

Does Brello Health charge the same tirzepatide price at every dose?

Brello's public checkout pages do not publish separate pricing tiers by dose. The $499 rate for an 11-week supply was captured without dose-specific breakdowns. Contact Brello support before ordering to confirm whether moving from 2.5 mg to 5 mg or higher changes your per-cycle cost, or whether the $499 rate remains flat across all doses.

Why is Brello's effective monthly rate higher than the advertised $166.33 per month?

Brello markets tirzepatide as $166.33 per month by dividing $499 by three. However, an 11-week cycle is approximately 2.54 calendar months, so over a full year (52 weeks) the $499 charge recurs 4.727 times. That yields an annualized cost of $2,359 (our calculation), or $196.56 per month when divided by twelve calendar months. Both figures are accurate within their stated frames; the difference matters when comparing annual budgets or preferring calendar-month thinking.

Can I pause my Brello Health subscription without losing my spot?

Brello's tirzepatide page states you may cancel anytime before the next 11-week rebill. The evidence does not confirm whether you can pause and later resume without re-enrolling, or how re-enrollment works if you cancel and wish to restart. Contact Brello support to clarify pause, skip-cycle, and re-enrollment policies before committing to your first $499 charge.

How does PlexusDx six-month prepaid compare to Brello's 11-week plan over a full year?

PlexusDx six-month prepaid costs $1,494 every six months ($249/month effective, prepaid), or $2,988 per year (our calculation). Brello's 11-week cycle costs $499 × 4.727 cycles = $2,359 per year (our calculation). Brello saves you $629 annually but charges you every 11 weeks instead of every six calendar months. Choose the model that matches your billing-cycle preference and budget rhythm.

Are Brello Health and PlexusDx tirzepatide medications FDA-approved?

No. Both programs dispense compounded tirzepatide, which is not FDA-approved. Compounded medications are not FDA-approved; FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies. Brello's pharmacy accreditation was not detailed in the captured evidence; confirm regulatory and pharmacy credentials at checkout.

Sources

• Brello Health tirzepatide pricing (tirzepatidewoo.brellohealth.com), accessed September 4, 2026
• Brello Health semaglutide pricing (brellohealth.com/home1), accessed September 4, 2026
• PlexusDx tirzepatide injection pricing (plexusdx.com/products/tirzepatide-injection), confirmed September 13, 2026
• PlexusDx Trustpilot rating (trustpilot.com/review/plexusdx.com), accessed September 9, 2026
• Brello Health Trustpilot profile, accessed September 4, 2026 (no rating/volume captured)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.